Novartis AG (NVS) to Acquire Chinook Therapeutics, Inc. (KDNY) for $3.2 Billion
Chinook Therapeutics, Inc. (NASDAQ: KDNY), a clinical-stage biotechnology company, has announced its agreement to merge with Novartis AG (NYSE: NVS). […]
Novartis AG (NVS) to Acquire Chinook Therapeutics, Inc. (KDNY) for $3.2 Billion Read More »
